Showing 101 - 120 results of 916 for search '"type 2 diabetes mellitus"', query time: 0.13s Refine Results
  1. 101
  2. 102

    Relationship between Altered Platelet Morphological Parameters and Retinopathy in Patients with Type 2 Diabetes Mellitus by Tolga Yilmaz, Ahu Yilmaz

    Published 2016-01-01
    “…This prospective study enrolled 85 healthy controls (HCs) (group 1) and 262 patients with Type 2 diabetes mellitus (T2DM). Patients were subclassified into three groups according to ocular findings: no DR (group 2; n=88); nonproliferative DR (group 3; n=88), and proliferative DR (group 4; n=86). …”
    Get full text
    Article
  3. 103

    Molecular Structure, Membrane Interactions, and Toxicity of the Islet Amyloid Polypeptide in Type 2 Diabetes Mellitus by Lucie Caillon, Anais R. F. Hoffmann, Alexandra Botz, Lucie Khemtemourian

    Published 2016-01-01
    “…Human islet amyloid polypeptide (hIAPP) is the major component of the amyloid deposits found in the pancreatic islets of patients with type 2 diabetes mellitus (T2DM). Mature hIAPP, a 37-aa peptide, is natively unfolded in its monomeric state but forms islet amyloid in T2DM. …”
    Get full text
    Article
  4. 104
  5. 105
  6. 106
  7. 107
  8. 108

    Sociodemographic and Pathological Characterization of Patients with Type 2 Diabetes Mellitus Treated in Peru Medical Center by José Ander Asenjo Alarcón

    Published 2021-06-01
    “…<strong>Background:</strong> type 2 diabetes mellitus is a very frequent chronic disease. …”
    Get full text
    Article
  9. 109
  10. 110

    Hypermethylation in Calca Promoter Inhibited ASC Osteogenic Differentiation in Rats with Type 2 Diabetic Mellitus by Lei Wang, Feng Ding, Shaojie Shi, Xingxing Wang, Sijia Zhang, Yingliang Song

    Published 2020-01-01
    “…The abnormal environment of type 2 diabetes mellitus (T2DM) leads to a substantial decrease in osteogenic function of stem cells. …”
    Get full text
    Article
  11. 111
  12. 112
  13. 113

    The Effects of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Disease Risks in Type 2 Diabetes Mellitus by Pegah Yousefzadeh, Xiangbing Wang

    Published 2013-01-01
    “…DPP-4 inhibitors have some CV protective effects in type 2 diabetes mellitus (T2DM) in addition to their antidiabetic actions. …”
    Get full text
    Article
  14. 114

    Impact of type 2 diabetes mellitus on low-grade inflammation in patients with ST-elevated myocardial infarction by M.V. Bielinskyi, N.M. Seredyuk, A.I. Vytryhovskiy, V.D. Koroliuk

    Published 2023-12-01
    “…Chronic low-grade inflammation has emerged as a hallmark of type 2 diabetes mellitus (T2DM), contributing significantly to the pathogenesis of various cardiovascular diseases, notably ST-elevated myocardial infarction (STEMI). …”
    Get full text
    Article
  15. 115

    Cardiovascular Risk Factors and Distributions of the Ankle-Brachial Index among Type 2 Diabetes Mellitus Patients by Badaruddoza Doza, Manpreet Kaur, Sonia Chopra, Rohit Kapoor

    Published 2012-01-01
    “…The aim of present study is to observe the association between the levels of ankle-brachial index (ABI) and cardiovascular risk factors among people with type 2 diabetes mellitus in north India. A cross-sectional study was carried out at a centre for heart and diabetic clinic in the state of Punjab on 1121 subjects (671 males and 450 females) with type 2 diabetes mellitus. …”
    Get full text
    Article
  16. 116

    Impact of type 2 diabetes mellitus on results in the animal naming test in patients with and without liver cirrhosis. by Eva Maria Schleicher, Julia Tuchscher, Matthias Weber, Peter Robert Galle, Marcus-Alexander Wörns, Simon Johannes Gairing, Christian Labenz

    Published 2025-01-01
    “…<h4>Results</h4>Type 2 diabetes mellitus was present in 79 (29.5%) patients with cirrhosis and MHE according to PHES was detected in 81 (30.2%) patients. …”
    Get full text
    Article
  17. 117
  18. 118
  19. 119
  20. 120